title: Bacille Calmette-Guerin disease following Bacille Calmette-Guerin vaccination of an HIV-infected health-care worker.
abstract: We present a case of Bacille Calmette-Guerin (BCG) lymphadenitis following immunization of a health-care worker with risk factors for HIV but undiagnosed infection. This case highlights the potential risks of BCG and clearly demonstrates the need to consider HIV testing in all patients prior to BCG vaccination.
authors: The Jefferiss Wing Centre for Sexual Health, Imperial College Healthcare NHS Trust, St Mary's Hospital, London.
authors: J H
authors: JH
authors: Vera
authors: S C
authors: SC
authors: Hill
authors: L
authors: L
authors: Rubinstein
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use; D001500:BCG Vaccine / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D015658:HIV Infections / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D006282:Health Personnel; D006801:Humans; D009163:Mycobacterium bovis / Q000276:immunology*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy / Q000382:microbiology* / Q000821:virology*; D014376:Tuberculosis / Q000175:diagnosis / Q000188:drug therapy / Q000821:virology*
chemical_list: D019380:Anti-HIV Agents; D001500:BCG Vaccine